Bristol-Myers announced that its Board of Directors has declared a quarterly dividend of 57c per share on the 10c par value common stock of the company. The dividend is payable on February 1, 2023 to stockholders of record at the close of business on January 6, 2023. This quarterly dividend represents a 5.6% increase over last year’s quarterly dividend rate of 54c per share. At this quarterly dividend rate, subject to the normal quarterly review by the Board of Directors, the annual dividend rate for the fiscal year 2023 is $2.28 per share. This marks the fourteenth consecutive fiscal year that the company has increased its dividend and the 91st consecutive year that the company has paid a dividend.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on BMY:
- Cantor biotech/biopharma analysts hold an analyst/industry conference call
- Oppenheimer emerging biotech analysts to hold analyst/industry conference call
- Bristol-Myers, Envisagenics announce research collaboration
- CytomX Therapeutics downgraded to Market Perform from Outperform at BMO Capital
- Society for Immunotherapy of Cancer to hold a meeting